Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 172.90 EUR | +0.58% |
|
+6.27% | -17.67% |
| 07-28 | SARTORIUS STEDIM BIOTECH : Buy rating from Bernstein | ZD |
| 07-24 | SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating | ZD |
| Market Cap | 16.82B 19.37B 15.68B 14.41B 27.25B 1,843B 27.55B 185B 72.29B 921B 72.76B 71.16B 3,052B | P/E 2026 * |
44.5x | P/E 2027 * | 34.4x |
|---|---|---|---|---|---|
| Enterprise Value | 18.83B 21.69B 17.56B 16.13B 30.51B 2,063B 30.84B 207B 80.93B 1,031B 81.45B 79.67B 3,417B | EV / Sales 2026 * |
6.02x | EV / Sales 2027 * | 5.36x |
| Free-Float |
28.47% | Yield 2026 * |
0.48% | Yield 2027 * | 0.59% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +0.58% | ||
| 1 week | +6.27% | ||
| Current month | +3.72% | ||
| 1 month | -4.05% | ||
| 3 months | +10.34% | ||
| 6 months | -9.95% | ||
| Current year | -17.67% |
| 1 week | 166 |  | 175.2 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.58% | +6.27% | +0.73% | -36.08% | 19.24B | |
| -1.55% | +0.93% | -17.15% | -1.93% | 185B | |
| -0.55% | +2.35% | -3.51% | +2.02% | 111B | |
| -0.68% | -1.57% | +6.22% | +60.05% | 60B | |
| +2.63% | +4.85% | +48.14% | +59.49% | 53.9B | |
| -0.05% | +7.05% | -3.54% | -36.69% | 46.9B | |
| +3.88% | +5.89% | - | - | 34.22B | |
| -0.42% | +18.50% | +9.66% | -28.78% | 32.95B | |
| +0.24% | +5.29% | +45.77% | -5.67% | 24.49B | |
| +0.09% | +6.62% | +2.64% | +3.26% | 22.67B | |
| Average | +0.43% | +5.21% | +9.88% | +1.74% | 59.07B | |
| Weighted average by Cap. | -0.18% | +3.83% | +1.34% | +5.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.6B 2.92B 2.68B 5.07B 343B 5.12B 34.37B 13.44B 171B 13.52B 13.23B 567B | 3.47B 3.99B 3.23B 2.97B 5.62B 380B 5.68B 38.1B 14.9B 190B 14.99B 14.66B 629B |
| Net income | 376M 433M 351M 322M 609M 41.22B 616M 4.14B 1.62B 20.6B 1.63B 1.59B 68.27B | 480M 553M 448M 412M 778M 52.63B 787M 5.28B 2.06B 26.31B 2.08B 2.03B 87.18B |
| Net Debt | 2.01B 2.32B 1.87B 1.72B 3.26B 220B 3.29B 22.1B 8.64B 110B 8.7B 8.51B 365B | 1.77B 2.04B 1.65B 1.51B 2.86B 194B 2.9B 19.44B 7.6B 96.85B 7.65B 7.48B 321B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | €172.90 | +0.58% | 74,728 |
| 26-08-03 | €171.90 | +3.12% | 65,593 |
| 26-07-31 | €166.70 | -2.00% | 137,690 |
| 26-07-30 | €170.10 | -0.64% | 57,064 |
| 26-07-29 | €171.20 | +0.71% | 86,575 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
